LTA4H
Leukotriene A-4 hydrolase
Also known as: LKHA4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P09960
- Gene
- LTA4H
- Ensembl
- ENSG00000111144
- Chromosome
- 12
- Canonical length
- 611 aa
- Protein class
- Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is an enzyme that contains both hydrolase and aminopeptidase activities. The hydrolase activity is used in the final step of the biosynthesis of leukotriene B4, a proinflammatory mediator. The aminopeptidase activity has been shown to degrade proline-glycine-proline (PGP), a neutrophil chemoattractant and biomarker for chronic obstructive pulmonary disease (COPD). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2015]
Canonical amino-acid sequenceUniProt
611 residues, UniProt reviewed canonical sequence.
>P09960|LTA4H
1 MPEIVDTCSL ASPASVCRTK HLHLRCSVDF TRRTLTGTAA LTVQSQEDNL RSLVLDTKDL
61 TIEKVVINGQ EVKYALGERQ SYKGSPMEIS LPIALSKNQE IVIEISFETS PKSSALQWLT
121 PEQTSGKEHP YLFSQCQAIH CRAILPCQDT PSVKLTYTAE VSVPKELVAL MSAIRDGETP
181 DPEDPSRKIY KFIQKVPIPC YLIALVVGAL ESRQIGPRTL VWSEKEQVEK SAYEFSETES
241 MLKIAEDLGG PYVWGQYDLL VLPPSFPYGG MENPCLTFVT PTLLAGDKSL SNVIAHEISH
301 SWTGNLVTNK TWDHFWLNEG HTVYLERHIC GRLFGEKFRH FNALGGWGEL QNSVKTFGET
361 HPFTKLVVDL TDIDPDVAYS SVPYEKGFAL LFYLEQLLGG PEIFLGFLKA YVEKFSYKSI
421 TTDDWKDFLY SYFKDKVDVL NQVDWNAWLY SPGLPPIKPN YDMTLTNACI ALSQRWITAK
481 EDDLNSFNAT DLKDLSSHQL NEFLAQTLQR APLPLGHIKR MQEVYNFNAI NNSEIRFRWL
541 RLCIQSKWED AIPLALKMAT EQGRMKFTRP LFKDLAAFDK SHDQAVRTYQ EHKASMHPVT
601 AMLVGKDLKV DLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LTA4H can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.2
- Highest tissue expression
- 180 nTPM
Expression across tissuesHPA
Tissue
- lung: 180 nTPM
- bone marrow: 170 nTPM
- esophagus: 104 nTPM
- tonsil: 90 nTPM
- ovary: 89 nTPM
- duodenum: 74 nTPM
Single-cell type
- neutrophil progenitors: 498 nCPM
- neutrophils: 334 nCPM
- esophageal apical cells: 313 nCPM
- monocytes: 285 nCPM
- esophageal suprabasal cells: 225 nCPM
- alveolar cells type 2: 211 nCPM
Immune cell
- intermediate monocyte: 699 nTPM
- classical monocyte: 663 nTPM
- non-classical monocyte: 642 nTPM
- total PBMC: 591 nTPM
- myeloid DC: 282 nTPM
- naive B-cell: 158 nTPM
Brain region
- choroid plexus: 37 nTPM
- white matter: 36 nTPM
- cerebellum: 27 nTPM
- hypothalamus: 25 nTPM
- thalamus: 22 nTPM
- medulla oblongata: 21 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about LTA4H.
Disease | ImmuneIEDB
Conditions an epitope on LTA4H was assayed in.
- Behcet's disease T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.72
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.48
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- leukotriene biosynthetic process
- lipid metabolic process
- peptide catabolic process
- proteolysis
- response to peptide hormone
- response to zinc ion
- type I pneumocyte differentiation
Molecular functions
- aminopeptidase activity
- epoxide hydrolase activity
- metalloaminopeptidase activity
- peptidase activity
- RNA binding
- zinc ion binding
- leukotriene-A4 hydrolase activity
- tripeptide aminopeptidase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Peptidase M1, alanine aminopeptidase/leukotriene A4 hydrolase
- Peptidase M1, membrane alanine aminopeptidase
- Peptidase M1, leukotriene A4 hydrolase/aminopeptidase C-terminal
- Armadillo-type fold
- Peptidase M4/M1, CTD superfamily
- Aminopeptidase, leukotriene A4 hydrolase-like
- Peptidase M1, LTA-4 hydrolase/aminopeptidase, C-terminal domain superfamily
- Aminopeptidase N-like , N-terminal domain superfamliy
- Aminopeptidase N-like , N-terminal domain
- Leukotriene A4 hydrolase-like, catalytic domain
- Peptidase family M1 domain
- Leukotriene A4 hydrolase, C-terminal
- Peptidase M1 N-terminal domain
- Leukotriene A4 hydrolase/leucine aminopeptidase
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LTA4H as an antibody target. Whether an autoantibody or antibody against LTA4H could matter depends on whether native LTA4H is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LTA4H is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LTA4H as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...